UK markets closed

Capstone Therapeutics Corp. (CAPS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
5.00000.0000 (0.00%)
At close: 10:46AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
64,295
48,354
61,561
66,743
45,451
Cost of revenue
46,971
38,743
45,030
50,427
34,515
Gross profit
17,351
9,611
16,531
16,316
10,936
Operating expenses
Selling general and administrative
13,363
10,867
12,538
11,680
8,540
Total operating expenses
13,363
10,867
12,538
11,680
8,540
Operating income or loss
3,988
-1,256
3,993
4,636
2,396
Interest expense
1,188
1,529
895
1,059
710
Total other income/expenses net
-800
-800
-
780
-
Income before tax
2,800
-3,585
3,098
4,357
1,686
Income tax expense
-712
234
783
436
-8,486
Income from continuing operations
3,512
-3,819
2,315
3,921
10,172
Net income
3,512
-3,819
2,315
3,921
10,455
Net income available to common shareholders
336
-5,735
-10
563
8,530
Basic EPS
-31.27
-
-0.06
7.10
107.60
Diluted EPS
-31.27
-
-0.06
7.10
107.60
Basic average shares
157.61
-
157.61
79.277
79.277
Diluted average shares
157.61
-
157.61
79.277
79.277